About Parse Biosciences
Parse Biosciences is a company based in Seattle (United States) founded in 2018 by Geoff Krummel, Charlie Roco, and Alex Rosenberg. Parse Biosciences has raised $100.26 million across 7 funding rounds from investors including Marshall Wace, Janus Henderson Investors and Horizon Tech Finance. Parse Biosciences has completed 1 acquisition, including Biomage. Parse Biosciences operates in a competitive market with competitors including Neogen, Sino Biological, Qiagen, Biofidelity and GenScript, among others.
- Headquarter Seattle, United States
- Founders Geoff Krummel, Charlie Roco, Alex Rosenberg
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$100.26 M (USD)
in 7 rounds
-
Latest Funding Round
Not available
-
Investors
Marshall Wace
& 8 more
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Parse Biosciences
Unlock access to complete
Funding Insights of Parse Biosciences
Parse Biosciences has successfully raised a total of $100.26M across 7 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Parse Biosciences
Parse Biosciences has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Marshall Wace, Janus Henderson Investors and Horizon Tech Finance.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Multiple sectors are targeted for venture capital investments.
|
Locked | Locked | Locked |
Investor details for Parse Biosciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Parse Biosciences
Parse Biosciences has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Biomage.
Investment portfolio details for Parse Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of a cloud-based cell and genomic sequence analysis platform for researchers
|
Locked | Locked | 2019 | Locked |
Complete acquisition details for Parse Biosciences
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Parse Biosciences
Detailed financials for Parse Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Parse Biosciences Comparisons
Peer comparison for Parse Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Parse Biosciences
Parse Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Neogen, Sino Biological, Qiagen, Biofidelity and GenScript, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Manufacturer of products in the areas of veterinary diagnostics, life sciences, DNA testing, and drug testing
|
|
| Locked | Locked | Locked |
Reagents and kits are provided for clinical research applications.
|
|
| Locked | Locked | Locked |
Products and reagents for molecular diagnostic assays are supplied.
|
|
| Locked | Locked | Locked |
Molecular diagnostic assays are developed for target DNA sequence detection.
|
|
| Locked | Locked | Locked |
Reagents and instruments are provided for life sciences research.
|
Detailed competitors of Parse Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Parse Biosciences
Complete news archive for Parse Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Parse Biosciences
Parse Biosciences was founded in 2018.
Parse Biosciences is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
Alex Rosenberg is the current CEO of Parse Biosciences. They have also founded this company.
Parse Biosciences is a funded company, having raised a total of $100.26M across 7 funding rounds to date.
Parse Biosciences was founded in 2018 in Seattle, United States, within the biotechnology sector. RNA-sequencing solution-based kits are developed for transcriptome analysis of health data. Solutions are provided to enable researchers to process fixed samples from various collection dates in one experiment, with oversight on sample handling to minimize errors. Barcoding is applied to label single-cell or single-nucleus suspensions for sequencing, complemented by data analysis tools.
Parse Biosciences's top competitors include Neogen, Sino Biological and Qiagen.
Parse Biosciences has made 1 acquisition, including Biomage.
Parse Biosciences has 9 investors. Key investors include Marshall Wace, Janus Henderson Investors, Horizon Tech Finance, Soleus Capital, and Bioeconomy Capital.